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Best Practices for Virtual Care: A Consensus Statement From
the Canadian Rheumatology Association
Claire E.H. Barber1, Deborah M. Levy2, Vandana Ahluwalia3, Arielle Mendel4,
Regina Taylor-Gjevre5, Tommy Gerschman6, Sahil Koppikar7, Konstantin Jilkine8,
Elizabeth Stringer9, Cheryl Barnabe1, Sibel Zehra Aydin10, Nadia Luca11, Roberta Berard12,
Keith Tam13, Jennifer Burt14, Jocelyne C. Murdoch15, Graeme Zinck16, Therese Lane17,
Jennifer Heeley16, Megan Mannerow16, Renee Mills16, Linda Wilhelm17, Nicole M.S. Hartfeld13,
and Brent Ohata18
ABSTRACT. Objective. To develop best practice statements for the provision of virtual care in adult and pediatric rheumatology for the Canadian Rheumatology Association’s (CRA) Telehealth Working Group (TWG).
Methods. Four members of the TWG representing adult, pediatric, university-based, and community rheumatology practices defined the scope of the project. A rapid literature review of existing systematic reviews,
policy documents, and published literature and abstracts on the topic was conducted between April and
May 2021. The review informed a candidate set of 7 statements and a supporting document. The statements
were submitted to a 3-round (R) modified Delphi process with 22 panelists recruited through the CRA and
patient advocacy organizations. Panelists rated the importance and feasibility of the statements on a Likert
scale of 1–9. Statements with final median ratings between 7–9 with no disagreement were retained in the
final set.
Results. Twenty-one (95%) panelists participated in R1, 15 (71%) in R2, and 18 (82%) in R3. All but 1 statement met inclusion criteria during R1. Revisions were made to 5/7 statements following R2 and an additional statement was added. All statements met inclusion criteria following R3. The statements addressed the
following themes in the provision of virtual care: adherence to existing standards and regulations, appropriateness, consent, physical examination, patient-reported outcomes, use in addition to in-person visits, and
complex comanagement of disease.
Conclusion. The best practice statements represent a starting point for advancing virtual care in rheumatology. Future educational efforts to help implement these best practices and research to address identified
knowledge gaps are planned.
Key Indexing Terms: rheumatology, virtual care
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The rheumatology community has a long history of virtual
patient care, often referred to as “telerheumatology.”1 Virtual
care is an emerging term adopted by the Canadian Medical
Association (CMA) as “any interaction between patients and/
or members of their circle of care, occurring remotely, using any
forms of communication or information technologies with the
aim of facilitating or maximizing the quality and effectiveness of
patient care.”2 Prior to the coronavirus disease 2019 (COVID-19)
pandemic, virtual care was practiced infrequently in rheumatology3 and was used primarily to deliver care to more rural and
remote regions across Canada. This was often through telehealth
with a physical exam presenter conducting a musculoskeletal
exam at the patient’s site with the rheumatologist remaining at
their usual clinical site.4
During the COVID-19 pandemic, there has been a rapid
increase in virtual care in many specialties, including rheumatology, where it poses unique challenges. Rheumatologic
conditions often affect multiple organ systems, some of which
can be challenging to assess by virtual care. Additionally, the
standard of care for many autoimmune inflammatory diseases is
“treating to target,”5,6,7 which involves the frequent reassessment
of disease activity; this reassessment may, depending on the
disease, include review of laboratory and other appropriate diagnostic tests and a physical exam (ie, tender and/or swollen joint
count). Additional challenges for both patients and rheumatology healthcare providers have included overcoming technological barriers, determining the appropriateness of virtual visits,
involving learners in virtual care, and determining the long-term
effect of virtual care on patient outcomes.
To address rheumatologists’ needs for guidance on best
practices for virtual care, the Canadian Rheumatology
Association (CRA) convened the Telehealth Working Group
(TWG) on virtual care in October 2020. The group deployed
a survey in December 2020 to better understand Canadian
rheumatologists’ virtual care practices and knowledge needs,8
and then developed the CRA’s virtual care position statement.9 Development of rheumatology virtual care best practice
guidance was recognized as a potentially valuable additional
support for clinicians.
Alliance; 18B. Ohata, MD, FRCPC, Clinical Assistant Professor, Department
of Medicine, Division of Rheumatology, University of British Columbia,
Vancouver, British Columbia, Canada.
DML received honoraria from Amgen, Janssen, Novartis, and Sobi. VA
received honoraria from AbbVie, Amgen/Wyeth, Janssen, Roche, UCB,
Sandoz, Novartis, Fresenius Kabi, Sobi, Gilead, and Pfizer. KJ received
honoraria from AbbVie, Lilly, Janssen, Novartis, Pfizer, and UCB. CB
received honoraria from Sanofi, Gilead, Celltrion, Novartis, and Pfizer. SZA
received honoraria from AbbVie, Celgene, UCB, Novartis, Janssen, Pfizer,
and Sanofi, and holds shares in Clarius. BO received honoraria from AbbVie,
Gilead, Janssen, Novartis, Pfizer, Sandoz, Celltrion, Fresenius Kabi, and Eli
Lilly. The remaining authors declare no conflicts of interest relevant to this
article.
Address correspondence to Dr. C.E.H. Barber, 3280 Hospital Dr. NW,
HMRB Building, Room 451, Calgary, AB T2N 4N1, Canada.
Email: cehbarbe@ucalgary.ca.
Accepted for publication January 14, 2022.

METHODS

There were 4 phases in the development of the best practice statements.
Phase 1: Drafting initial topics for best practice statements. In phase 1, a core
working group of 4 rheumatologists (1 pediatric [DML], and 3 adult rheumatologists [BO, CEHB, VA], 2 of whom were community-based) met 4
times and ascertained the scope and approach for the project, which was
then approved by the TWG. An initial list of potential topics was developed based on group discussion and in response to the results of the CRA’s
virtual care survey.8 The scope included the provision of virtual care in rheumatology across adult and pediatric populations. Virtual care education for
rheumatology trainees was excluded from the scope of this work.
Phase 2: Evidence reviews for best practices in virtual care. To support the
best practice statements, a rapid review was conducted using methodology proposed by the National Collaborating Center for Methods and
Tools10 between March and April 2021. The review was conducted by a
single primary reviewer skilled in literature reviews (CEHB). Literature
to support the best practice statements was derived through a review of
the following sources: (1) existing systematic reviews on relevant topics
including virtual care in rheumatology identified through targeted literature searching,11,12,13,14 mobile health (mHealth) applications or electronic
health (eHealth) technologies,15,16,17 patient-reported joint exams in rheumatology,18,19 and diagnostic accuracy of virtual care20; (2) reviews of best
practices, guidelines, and policy documents on virtual care from other organizations in Canada, the US, Europe, and Australia; (3) abstracts from the
rheumatology scientific meetings since 2020, including the CRA and the
American College of Rheumatology (ACR) Annual Scientific Meetings; (4)
Medical Subject Headings (MeSH) term search of Pubmed from database
inception including the terms “telemedicine” AND “rheumatic diseases”
conducted on April 20, 2021; (5) a Cochrane library search from database
inception conducted on April 20, 2021 (“telehealth” rheumatology); and
(6) a hand search of the literature conducted by members of the TWG to
provide any additional documents on the provision of virtual care that were
available provincially/locally.
Data from the rapid literature review were extracted using a standardized format to document the purpose, approach, and main findings of each
study or guidance. Articles that were included in the systematic reviews of
rheumatology virtual were not reabstracted.
Phase 3: Development of the best practice statements draft. Initial drafts of
the best practice statements were compiled by the core working group. The
group used the Canadian Quality and Patient Safety Framework for Health
Services,21 developed by the Canadian Patient Safety Institute, as a framework for creating the best practice statements. The framework outlines 5
overarching goals for healthcare: people-centered care, safe care, accessible care, appropriate care, and integrated care.21 The group also reviewed
equity considerations for each best practice recommendation using the
PROGRESS-Plus tool.22 This tool can be used to help understand which
populations face inequities in social determinants of health.
Phase 4: 3-round modified Delphi consensus process to finalize best practice statements. Panelists in the modified Delphi panel included rheumatologists, allied healthcare providers (AHPs), patients, and parents.
Rheumatologists and AHPs were recruited through the CRA’s TWG and
Quality of Care Committees, and patients were recruited from 2 organizations (Cassie + Friends, a pediatric rheumatology patient organization, and
the Canadian Arthritis Patient Alliance). Panelists were provided a background description of the project, including a summary of the results of the
literature review, the candidate best practice statements, and the associated
proposed rationale. A 1-hour teleconference was held to review this information and outline the Delphi process. Next, participants were sent an electronic survey for round 1 voting and asked to answer 2 questions on a Likert
scale of 1–9 for each draft best practice statement: (1) How important is this
“best practice” in providing high-quality virtual rheumatology care (1 = not
important at all, 9 = extremely important); and (2) How feasible/easy do
you think it is to do this “best practice” (1 = not feasible at all, 9 = extremely
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evidence, signaling the need for more research on the equity
considerations of virtual care delivery in rheumatology.
Delphi panel results. Twenty-two panelists agreed to participate
in the panel; 21 (95%) participated in round 1, 15 (68%) in
round 2, and 18 (82%) in round 3. There were representatives
from 10 Canadian provinces and territories (Supplementary
Table 4, available with the online version of this article). Of
those who responded to demographic questions (n = 20), 15
(75%) were female and 5 (25%) were male. Participants were
asked about their experience with rheumatic conditions and
could select multiple roles. Fourteen participants indicated
they were healthcare providers (6 adult and 4 pediatric rheumatologists, 3 AHPs, and 1 trainee) and 9 were persons with
a lived experience with a rheumatologic condition (patient
or parent). Four healthcare providers worked in outreach
clinics and/or traveled to a remote site for clinics, 9 worked at
university-based clinics, and 2 in community-based clinics.
During round 1 voting, all but 1 of the 7 statements met
criteria for inclusion in the final set (Supplementary Table 5,
available with the online version of this article). There was
concern about the feasibility of the 4th statement on the
topic of virtual physical exam, leading to a median rating
of 6. Despite high ratings of all the other statements in the
domains of importance and feasibility, participants had
several comments about the wording of the statements; these
comments were collected during round 1 and discussed during
round 2. This prompted revision of 5 of the original statements
(Supplementary Table 6).

feasible). Open text boxes were available for participants to share their
response rationale. Participants had approximately 10 days to provide their
votes.
In round 2, a facilitated discussion was held by teleconference with
panelists to review and discuss the group ratings. Following the group
discussion, the survey was readministered for the final vote using the same 2
questions for each statement, as described for round 1. To be included in the
final set of best practice statements, a median vote of 7–9 with no disagreement was required. Disagreement was defined according to the RAND/
University of California Los Angeles Appropriateness Method23 when the
interpercentile range for a particular question was larger than the interpercentile range adjusted for symmetry.
All participants in the Delphi panel provided informed consent to
participate and the study was approved by the University of Calgary
Conjoint Health Research Ethics Board (REB21-0569).

RESULTS
Development of candidate best practice statements. Results of
the rapid review are shown in Supplementary Figure 1 and
Supplementary Tables 1–3 (available with the online version of
this article). These results informed the generation of 7 candidate best practice statements for virtual care in rheumatology.
During the development process, the statements were mapped
to 5 overarching goals for health services from the Canadian
Quality and Patient Safety Framework.21 Table 1 describes the
relationship between the statements and 5 overarching goals for
safe and high-quality care.
Table 2 provides considerations for the application of the
statements on rheumatology virtual care based on equity considerations.22 In many instances the rapid review discovered little

Table 1. Quality and patient safety considerations when developing the best practice statements (BPS) for rheumatology virtual care.
Goals from the Canadian Quality and Patient Safety Framework for
Health Services21

How the Framework Was Considered in the Development of the BPS for
Virtual Care

People-centered care: “People using health services are equal partners
•
in planning, developing, and monitoring care to make sure it meets 		
their needs and to achieve the best outcomes.”
•
		
Safe care: “Health services are safe and free from preventable harm.”
•
		
		
•
		
Accessible care: “People have timely and equitable access to
•
quality health services.”		
•
		
		
		
Appropriate care: “Care is evidence-based and people-centered.”
•
		
		
•
		
Integrated care: “Health services are continuous and well-coordinated,
•
promoting smooth transitions.”		
•
		
a

Virtual care is a shared decision between healthcare providers and
patients (see BPS 3a).
The development of the BPS should include persons living with
rheumatic diseases and their families.
Various considerations need to be taken into account to ascertain the 		
medical appropriateness of virtual care to reduce any safety considerations 		
and avoid harm (see BPS 2a).
Patient privacy, consent, and confidentiality are important considerations 		
(see BPS 1a).
Accessibility to scarce rheumatology resources should be considered when
determining the appropriateness of virtual care (see BPS 2a).
Accessible care is an overarching principle in this document, as when used 		
appropriately, virtual care can increase access to care for many individuals 		
living with rheumatic diseases, especially in underserviced, rural, and remote
areas in Canada.
Various considerations need to be taken into account to ascertain the
medical appropriateness of virtual care to ensure optimal outcomes
(see BPS 2a).
Appropriate physical exam techniques should be used and
patient-important outcomes need to be monitored (see BPS 4,5a).
Virtual care may be used in between scheduled appointments to enhance
care (BPS 6a).
In complex comanagement of disease, virtual care may be used to enhance 		
communication between providers (BPS 7a).

BPS can be found in Table 3.
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Table 2. Equity considerations22 when applying best practice statements to rheumatology virtual care.
Equity Consideration

Rationale

Place of residence
• Access to high-speed internet and/or cellular service may affect accessibility of virtual care. This often varies along urban/rural
		divides.2
• Rheumatologists are located primarily in major urban centers across Canada, and residing outside of these centers may
		 adversely affect access to in-person visits. Access may be improved through virtual care.
• There may be limited access to presenters skilled in musculoskeletal exam (eg, ACPAC-trained extended role practitioners).
• There may be different license requirements that affect access to virtual care in different provinces across Canada.2
• Access to medical charts (eg, having a single patient chart) varies in different jurisdictions and may affect connectivity and
		 virtual care.2
Race/ethnicity/
• The use of virtual care should improve and not exacerbate existing inequities in healthcare delivery and outcomes in Black,
culture/language		 Indigenous, other people of color, and other minority populations living with rheumatic diseases (further research is needed
		 in this area of rheumatology).
• Translation services should be used to facilitate communication with patients when required using virtual care.
• When developing mHealtha, eHealthb interventions to support care, or educational resources delivered virtually, they must be
		 translated into languages prevalent in the population served and be culturally appropriate (further research is needed in this
		 area of rheumatology).
Occupation
• The use of virtual care may be highly appropriate for individuals in a variety of occupations, especially those who may not be
		 readily able to take time out of work to come to in-person appointments.
• The safety of doing virtual care appointments while at work should still be considered (eg, not operating heavy machinery or
		 driving during a virtual appointment).
• The privacy of virtual appointments conducted at work should be considered.
Gender/sex
• Gender/sex considerations in virtual care have not been broadly investigated (further research is needed in this area of
		rheumatology).
• For those in caregiver roles, virtual care may offer more convenience as there is less of a need to find alternative caregivers.
Religion
• It is possible that some religious beliefs may limit the access of virtual care (further research is needed in this area).
Education
• Lower health and digital literacy may affect ability to use virtual care (further research is needed in this area).
Socioeconomic status
• Access to a computer, smart phone, or internet may be limited for those with lower socioeconomic means, limiting access to
		 virtual care.
Social capital
• An individual’s networks and relationships may influence knowledge of virtual care resources.
• Some types of virtual care may enhance social capital by increasing social networking and peer support.
Personal characteristics
• Age may influence patient acceptability of certain virtual care modalities, but access to technology and digital literacy may be
associated with 		 more important factors.
discrimination (eg, age,
• Additional technology considerations for individuals who are blind, deaf, or hard of hearing may be required
disability)		 when considering the most appropriate modality for virtual care and any specific adaptations.
• Individuals with significant mobility impairment may find a virtual visit more convenient and comfortable.
Time-dependent
• Virtual care may be used to facilitate triage and reduce waiting times for care.
relationships (eg, transitions • Virtual care may be used to enhance communication between providers for complex cases.
between care providers)
• Virtual care (especially through nurse-led help lines) may facilitate access to care in between appointments.
Mobile health (mHealth) refers to the delivery of healthcare and innovations in healthcare using mobile technologies. b Electronic health (eHealth) refers to
innovations in the use of information and communication in healthcare. ACPAC: Advanced Clinical Practitioner in Arthritis Care.

a

Based on feedback, an additional statement was generated to
address obtaining a medical history from a proxy decision maker
and submitted for voting in round 3. While it was felt that ideally,
it is best practice that patients are present for all their virtual care
encounters, in select circumstances patient family members or
caregivers may be substitute decision makers to maintain continuity of care. Examples of such scenarios may include when a
pediatric rheumatologist needs to communicate investigation
results and treatment plans to the parents of a young child due
to age of consent. In adult rheumatology, this can occur with
elderly patients who may have dementia and have an advanced
directive in place to help guide their care. While the proposed
statement regarding proxy decision makers technically met
panel thresholds set for inclusion, there were concerns that it
may not adequately represent all appropriate proxy scenarios.
Additionally, some panelists expressed concern it may be used

to justify excluding patients from participating in care. For
these reasons, this statement was ultimately removed from the
final set.
The final wording and voting results for the 7 statements are
shown in Table 3 and a rationale for each is discussed below.
Best practice statements
1. Rheumatologists should adhere to national recommendations on best practices, and provincial standards and regulations for virtual care, including licensing considerations, patient
privacy, confidentiality, documentation, and consent.
Rationale. In Canada, physicians are licensed provincially and
must adhere to the provincial regulations of their licensing
bodies. Organizations including the Canadian Medical
Protective Agency (CMPA) and the CMA, among others,
have also developed specific recommendations to consider for
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Table 3. Round 3 Delphi panel ratings on best practice statements for virtual care in rheumatology.
Best Practice Statement
		
		

Delphi Median Ratings
(IPRAS Rule Decision)
Importance
Feasibility

1. Rheumatologists should adhere to national recommendations on best practices, and provincial
standards and regulations for virtual care, including the following: licensing considerations, patient
privacy, confidentiality, documentation, and consent.
2. The appropriateness of virtual care for a rheumatology encounter should be considered based on
the following factors: access to local rheumatology care; reason for, urgency, and complexity of the
clinical encounter (including clinical, cultural, and language considerations); patient preferences;
and type of virtual care available.
3. If virtual care is determined to be medically appropriate, the rheumatology provider should ensure
that the provision of care is a shared decision with patients and that patient consent is documented.
4. The standard of care for physical exam by virtual care should allow for appropriate clinical decision
making. If this is not possible, then an in-person physical exam is required and should be completed
(either at an in-person rheumatologist visit or by a skilled presenter at a remote site).
5. Where appropriate, patient-reported outcomes that help direct approaches for care should be used
during virtual encounters.
6. Virtual care may be used in addition to in-person follow-ups to enhance care.
7. In complex comanagement of disease, virtual care may be used to enhance communication
between providers.

9 (Agreement)

8 (Agreement)

9 (Agreement)

8 (Agreement)

8.5 (Agreement)

8 (Agreement)

9 (Agreement)

8 (Agreement)

8 (Agreement)
9 (Agreement)
8.5 (Agreement)

8 (Agreement)
9 (Agreement)
7 (Agreement)

IPRAS: interpercentile range adjusted for symmetry.

the provision of virtual care. Selected resources are outlined in
Table 4 and include discussing the limitations of virtual care with
patients, obtaining and documenting consent for virtual care,
protecting the privacy and confidentiality of virtual care encounters, and ensuring appropriate documentation of virtual care
encounters and appropriate communication of the encounter to
other care providers.
2. The appropriateness of virtual care for a rheumatology
encounter should be considered based on the following factors:
access to local rheumatology care; reason for, urgency, and

complexity of the clinical encounter (including clinical, cultural,
and language considerations); patient preferences; and type of
virtual care available.
Rationale. Virtual care may be offered if medically appropriate. According to CMPA, “virtual care is not a substitute for
in-person assessments or clinical examinations,”24 and it is also not
a substitute for attending the emergency department for urgent
evaluation if required. Various patient, clinical, and system-level
factors need to be considered to determine the appropriateness
of a virtual care encounter. Based on multiple systematic reviews

Table 4. Key points to consider when providing virtual care.
General considerations
• Telephone, videos, and/or photos may not provide a substitute for in-person care.
• An in-person visit may be necessary to complete the assessment.
• Document data used to make a diagnosis and how these data were obtained.
• Document what could not be assessed due to the limitations of virtual care.
• Document who was present for the visit.
• Document clinical considerations and any impact of the type of visit on how diagnosis/approach was made.
• Document follow-up instructions provided to the patient.
• Ensure other care providers receive a document outlining care plan.
Consent considerations
• Obtain and document consent.
• Discuss clinical and/or technology limitations of virtual care.
• Discuss alternatives to virtual care.
• CMPA suggests considering PARQ to frame discussion, and to allow the patient to ask questions.
Helpful resources
• CMPA microlearning activities and resources: https://www.cmpa-acpm.ca/en/covid19/telehealth-and-virtual-care
• CMA Virtual Care Playbook and Virtual Care Taskforce: https://www.cma.ca/sites/default/files/pdf/Virtual-Care-Playbook_mar2020_E.pdf
• RCPSC links to provincial virtual care guidelines and resources: https://www.royalcollege.ca/rcsite/documents/about/
covid-19-resources-telemedicine-virtual-care-e
CMA: Canadian Medical Association; CMPA: Canadian Medical Protective Agency; PARQ: Procedure (virtual care), Alternatives, Risks, and Benefits;
RCPSC: Royal College of Physicians and Surgeons of Canada.
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Clinical Considerations

Types of Virtual Care Available

Patient Preferences and Access Considerations

Consider if routine vs emergent, and whether asynchronous
Telephone, asynchronous electronic
· May depend on access to internet,
vs synchronous discussion is clinically appropriate
communication, video consultation, 		 availability of a computer,
			
patient accesses, or patient portal for 		 and computer literacy
			
directly accessing and reviewing test
· Patients may also have varied individual
			
results		 preferences for telephone or asynchronous
						 notification of results, and/or accessing their
						 own results online
Stable disease (eg, may apply to a variety
· Whether a disease is stable or not may depend on
· Telephone or video consultations in the
· Access to rheumatologist (eg, virtual care may
of rheumatic conditions, including but 		 clinical factors (eg, stability of laboratory 		 short term for assessing disease activity for		 be the only option available)
not limited to gout, osteoporosis, PMR, 		 investigations, duration of disease, length		 DMARD or biologic renewals (note lack
· As above, access to internet and other
RA, vasculitis, connective tissue disease, 		 of stability) and patient experience with disease		 of evidence to date for long-term outcomes		 technologies may affect availability of
SpA, osteoarthritis, and JIA)
(eg, patient perception of any unmet care-related 		 from this strategy)		 virtual care
		 needs that would require an in-person assessment)
· If an extended-role practitioner is monitoring · Patient preference may vary depending on their
· Risk of missing subtle clinical findings		 physical exam periodically, virtual care could		 current needs, healthcare concerns, and other
			
be done indefinitely
work and social obligations that may affect ability
						 to attend in-person visits
Prescreening to assess suitability for
May help triage new and/or follow-up assessments
Telephone, electronic survey (note lack of
Need to ensure patient understands that the
virtual care vs in-person visit (may ensure for appropriateness for virtual care
widely used well-validated surveys), video
nature of the encounter is to assess needs and to
appropriate investigations done or avoid 			
consultation
help determine urgency of care.
misdirected referral)
New complex patients (eg, those with
Risk of missing subtle clinical findings must be
· Telephone-only appointments may be
· May depend on access to internet, availability of
SLE, vasculitis, undifferentiated
weighed against greater access to care, especially		 enhanced by discussion with another 		 a computer, and computer literacy. Patients
connective tissue disease), especially if
if no local rheumatologist is readily available		 healthcare provider to help relay clinical		 may also have varied individual preferences for
there is rapid development of symptoms 				 findings from physical exam		 telephone or videoconference.
or they are clinically unwell 			
· Videoconference directly with patients or
· Access to rheumatologist (eg, virtual care
				 with the assistance of an ERP to conduct 		 may be only option available).
				 and relay the physical exam findings
		
· eConsultation with local internist or GPs
				 for comanagement
New inflammatory disease with clear
· Seropositive RA, AS with sacroiliitis and HLA-B27,
Telephone, videoconference with or without
As above
serologic and/or imaging features		 select SLE casesa, gout
an ERP, eConsultation with local internist
· Risk of missing subtle clinical findings that must be
or GPs for comanagement
		 weighed against greater access to care (especially for
		 those with no local rheumatologist readily available)		
Undifferentiated disease
· Likely greater risk of missing clinical findings when
Telephone follow-up likely less appropriate,
As above
		 disease is undifferentiated.
unless for triage purposes
· Consider as preliminary to guiding additional
		 investigations and to help triage timing of
		 in-person review.		
Monoarthritis (new, cannot exclude
Requires arthrocentesis, which entails an in-person
NA
Rheumatologic emergency requires an
septic arthritis)
appointment but may be done by other practitioners 			
in-person arthrocentesis but can be done by a local
(eg, guided aspirate, primary care, local orthopedics if 			
provider (not necessarily a rheumatologist)
no rheumatologist readily available)

Reviewing test results

Reason for Clinical Encounter

Table 5. Considerations for the appropriateness of rheumatology virtual care encounters.

While SLE can be a complex disease involving multiple organ systems, in selected cases, initial diagnosis may be possible, as with other rheumatic conditions, using virtual care if appropriate history, laboratory,
and other investigations are available. AS: ankylosing spondylitis; DMARD: disease-modifying antirheumatic drug; eConsultation: electronic consultation; ERP: extended role practitioner; GP: general practitioner; IA: intraarticular; IM: intramuscular; IV: intravenous; JIA: juvenile idiopathic arthritis; NA: not applicable; PMR: polymyalgia rheumatica; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus;
SpA: spondyloarthritis.
a

If patients experience challenges with virtual
care and communication with their provider,
they should be able to have a face-to-face
encounter within a reasonable time frame

Intraoffice infusion/injection should be a shared
decision with the patient and options discussed
(if available) for alternatives that would not require
a visit					

Required infusion/injection of
· Depends on the type of agent being administered
NA
treatment (eg, in-office IM steroid,
· Choose a locally appropriate provider based on the 			
IA steroid, denosumab, administration 		 availability and nature of the injection/infusion			
of other IV or IM medications 					
including biologics)
“Failed” virtual care/challenges
Challenges with virtual care may include technology
· If challenges occur using one type of virtual
failures, identifying during the virtual visit that an 		 care and were specific to that modality
in-person visit is required, missed diagnosis, difficulties 		 (eg, internet connectivity), another modality
in rapport, communication, or other challenges
(eg, telephone) may be used if virtual care is
				 still appropriate
			
· Requesting the help of a skilled presenter may
				 help with some virtual care challenges
			
· If an in-person visit is required, it should
				 be offered

Patient Preferences and Access Considerations
Types of Virtual Care Available
Clinical Considerations
Reason for Clinical Encounter

Table 5. Continued.
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of virtual care in rheumatology, there is limited evidence for
the safety and efficacy of virtual care for many rheumatologic
conditions.12,13,14 There is conflicting evidence from small, older
studies that a videoconference for a new patient may offer a
similar diagnostic accuracy to an in-person assessment,1,25,26 and
additional high-quality studies are needed. Many (or all) of these
challenges may be alleviated by having a skilled presenter such
as an Advanced Clinician Practitioner in Arthritis Care27,28 at
the patient site to assist with examination. There is also limited
evidence for the long-term efficacy of virtual care, with most
data available for rheumatoid arthritis (RA).11 Only surveys29
and opinion-based recommendations exist as to the types of
rheumatic conditions that may be more or less appropriate for
virtual care.30,31 Further, patient factors such as comorbidities,
language, culture, and other factors should be considered when
determining appropriateness of virtual care.
A major factor is access to local in-person rheumatology
care, which is limited across many regions in Canada as rheumatologists are primarily located in larger urban centers. Virtual
care allows for greater access to rheumatology specialist care in
centers without a local rheumatologist and for greater continuity of care in centers where there may only be sporadic access
to rheumatology care due to traveling rheumatology clinics.
At the present time, given the varied potential clinical
scenarios encountered, we recommend an approach to determining the appropriateness of a virtual encounter that considers
multiple system, clinical, and patient factors (Table 5).
3. If virtual care is determined to be medically appropriate, the
rheumatology provider should ensure that the provision of care
is a shared decision with patients and that patient consent is
documented.
Rationale. Virtual care is not always medically appropriate
(statement 2, Table 3). If virtual care is appropriate, it should
be a shared decision with the patient, weighing the benefits
and risks of missing subtle clinical findings, which could affect
patient outcomes. Whereas the concept of consent is encompassed in statement 2, the panel voted to include statement 3
to emphasize this important concept (Supplementary Table 6,
available with the online version of this article). Various organizations have developed tools and templates to help educate
patients about virtual care and to document consent. The
Doctors Technology Office Virtual Care Toolkit32 developed
by the Doctors of BC is an example that has been referenced
in national CMA documents33 and adapted for use in other
provinces.
4. The standard of care for physical exam by virtual care should
allow for appropriate clinical decision making. If this is not
possible, then an in-person physical exam is required and should
be completed (either at an in-person rheumatologist visit or by a
skilled presenter at a remote site).
Rationale. A variety of tools for physical exams in virtual care
have been developed,34,35,36 although additional validation work
is required as they are largely consensus-based. A physical exam
may not always be required and depends on the nature of the
clinical encounter. In general, the required exam should be
directed based on clinical need to inform appropriate decision
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Table 6. Virtual physical exam considerations in rheumatology.
Virtual Physical Exam Approach

Clinical Considerations

Resource Considerations

Skilled presenter at a remote site

· There is evidence of the effectiveness of this approach11
More resource intensive (requires appropriate
· Limited evidence shows potential harms/delays in
resources and training; may involve travel of patients
		 diagnosis for unskilled remote presenters26
and skilled presenters to remote site)
Videoconference directly with patients · There have been some tools developed in pediatrics35
· May take more time to orient patients and
using a screening physical exam or 		 and adults34,36 for joint exam		 healthcare providers to new methods for physical
targeted exam for areas of concern
· Parts of physical exam limited or excluded due to 		 exam
		 technology limitations (eg, lung and cardiac
· Requires good internet connection and patient 		
		 auscultation)		 access to computer or a mobile phone with
				 videoconferencing capabilities
Asynchronous collection of
· A variety of tools have been developed and can be
· Collection electronically, by paper, or by
patient-reported joint counts/		 employed for the collection of patient-reported joint 		 telephone may all require different resource
disease activity or other patient-reported		 counts and disease activity 		 considerations
outcomes using a validated tool
· Most studies of joint counts have found good agreement · Incorporation into the electronic medical
		 between physicians and patients with tender joint counts, 		 record is ideal but not always feasible
		 but lower in swollen joint counts18,19
· More accurate in lower disease states
· Patient-reported outcome measures including pain, fatigue,
		 and functional status may be readily collected
Telephone description of active vs
· Not necessarily validated and may depend on patient
Less resource intensive but may require physical
stable joints or other clinical problems 		 report of physical exam findings18,19
exam (in person or by video) to confirm findings
of concern
· May be appropriate for stable follow-up patients
if concerned about flares/active disease and if major
		 with no new concerns
intensification of therapy is required
Photography
Resolution may not be sufficient for a joint exam but may
· Need a secure method to transmit photos
be useful for skin exam
· Patients require a smartphone with a camera

making. Table 6 outlines potential physical exam approaches and
their clinical and resource considerations.
5. Where appropriate, patient-reported outcomes (PROs) that
help direct approaches for care should be used during virtual
encounters.
Rationale. “Treat-to-target” refers to the frequent reassessment
of disease activity to direct the adjustment of disease-modifying
therapy to target low or inactive disease activity. This paradigm
is part of current guidelines for RA7 and is emerging for many
other rheumatic diseases. The reporting of patient disease activity
and/or functional status may be necessary to obtain coverage for
advanced therapies for many rheumatic diseases. In addition
to measures of disease activity, best practices for RA care may
include monitoring functional status.37,38 The ACR has recently
proposed modifications for the reporting of disease activity and
functional status in RA to account for the provision of virtual
care.39 Whereas recommended PROs do not require modification, some composite disease activity measures do require
patient-completed joint counts in lieu of provider joint counts,
and further validation of this approach is required.
For other rheumatic conditions, PRO measures may also
be readily obtained using electronic collection, through telephone or emailed surveys. For example, in juvenile idiopathic
arthritis, measures of functional status such as the Childhood
Health Assessment Questionnaire may be collected routinely. In
ankylosing spondylitis, disease activity indices may be recorded
including the Ankylosing Spondylitis Quality of Life score and
Bath Ankylosing Spondylitis Functional Index. A variety of PRO
measures have been proposed in systemic lupus erythematosus,40

but there remains limited guidance from professional societies as
to which measures should be routinely collected.
Other PROs may be appropriate to capture including
fatigue,41 pain,42 and measures of mental health.43,44 Additionally,
there may be specific considerations for the collection of PROs
in individuals with limited English proficiency or who have
limited health literacy.45,46
6. Virtual care may be used in addition to in-person follow-ups
to enhance care.
Rationale. In between rheumatology appointments, virtual care
has been used to support patients in a variety of ways. Some
examples include self-monitoring using mobile applications17,47;
nurse-led telephone lines48; patient self-management courses,
education, and/or resources47; methotrexate or biologic injection classes; and rapid-access rheumatology hotlines for practitioners to get timely specialist advice. Last, alternating virtual
and in-person appointments may be appropriate. Ongoing evaluation and reporting on these care strategies is suggested.
7. In complex comanagement of disease, virtual care may be
used to enhance communication between providers.
Rationale. Patients with rheumatic disease may have multiple
comorbidities that require consultation with different specialists. Across the country there are several examples of combined
clinics where a patient may be seen by ≥ 2 specialists in a single
clinical encounter to enhance communication and clinical decision making and reduce the need for multiple visits. These clinics
may be amenable to virtual encounters, if appropriate. Scenarios
where this may occur include comanagement of rheumatology
care with primary care providers or internists (eg, through
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structured educational and case-based discussion in Project
ECHO49), virtual transition clinics where adult and pediatric
rheumatologists assist young adults with transition to adult care,
or interdisciplinary visits (eg, with a social worker, physiotherapist, or nurse present for part of a visit or the entire visit). Further
research is needed in these advanced models of rheumatology
virtual care.
DISCUSSION
The COVID-19 pandemic has removed many logistical barriers
to virtual care that previously existed and improved our understanding of what constitutes an effective virtual care encounter.
We recommend that virtual care should continue following the
pandemic. The present work contributes an initial set of best
practice statements that can be expanded upon as we learn more
about the optimal delivery of virtual care in rheumatic diseases.
Our intent is not to replace good clinical judgment nor to
supplant regional regulatory requirements.
Importantly, through this work, several areas in need of
further study were highlighted, including a lack of studies
describing the diagnostic accuracy of virtual care modalities for
different rheumatic diseases and the safety and long-term efficacy of virtual care for follow-up. Further, limited information
exists on equity considerations in the provision of virtual care. A
research agenda for future areas of study of virtual care has been
outlined in Supplementary Table 7 (available with the online
version of this article).
Although the final panel ratings met the threshold for inclusion for all the statements through the Delphi process, some
points of discussion were identified. For example, some panelists emphasized that in certain regions of Canada, there are no
local rheumatologists or even skilled physical exam presenters,
and that all patient care may be delivered virtually with no availability of a future in-person rheumatology exam. The best practice statements should not be used to dissuade the provision of
rheumatology virtual care in such circumstances. Another point
of discussion arose around the final statement on patient proxies,
which was added during the Delphi process. Many physician
members of the panel indicated that this practice was ongoing in
select circumstances to ensure continuity of care. Patient panel
members in particular urged caution in the application of this
statement as active engagement in care for adults and children is
critical to optimize outcomes. Due to these concerns, as well as
challenges with wording a statement that would be appropriate
for all circumstances, it was removed from the final list.
While the process for the development of the best practice
statements was rigorous and transparent, there are important
limitations to highlight. First, a rapid review was used instead of
a systematic review and as such could have potentially resulted
in missed evidence. Additionally, the literature available was
limited, indicating that future research in this area is needed,
and many statements relied on expert opinion. Some Delphi
participants wanted better guidance on clinical scenarios most
appropriate for virtual care and on physical exam techniques
required. Unfortunately, given the existing challenges with
access to in-person rheumatology care in some regions, myriad
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possible clinical scenarios, and general lack of evidence, it was
not possible to generate prescriptive recommendations at this
time. Finally, whereas it is possible that a different panel composition may have generated different recommendations, our panel
was geographically diverse and well-balanced regarding participant type.
In conclusion, this work represents a starting point for future
research and practice advances in virtual care for rheumatology.
We anticipate increased research in this area over time and will
look to updating these statements in accordance with advances
in the field. In the interim, the work will be used to advocate for
resources and develop educational materials to support current
virtual care best practices for rheumatologists and persons living
with rheumatic diseases.
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